This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.
The European Commission (EC) has issued a marketing authorisation for Sanofi Genzyme’s therapy Nexviadyme (avalglucosidase alfa) for the long-term treatment of both late-onset and infantile-onset Pompe disease. ... In November 2021, Sanofi announced
Other client Gold winners were Allergan Aesthetics, an AbbVie Company, Campaign Against Living Miserably (CALM), Fresenius Kabi, Greenwich BioSciences, Mölnlycke, Novo Nordisk, Roche/Chugai, Sanofi Genzyme and ViiV Healthcare.
If approved, Dupixent – developed by Regeneron Pharmaceuticals and Sanofi Genzyme – would be used as a supplementary treatment for managing moderate-to-severe atopic dermatitis and is aimed at children whose condition
Sanofi Pasteur and Sanofi Genzyme will unite under the new brand image. ... Sanofi Pasteur and Sanofi Genzyme are focused on providing specialised care and vaccine research, respectively and will come together following the new branding as one united
The latest news from Sanofi Genzyme and Regeneron Pharmaceuticals shared positive results from the second phase 3 for Dupixent (dupilumab), a medicine the companies developed to target chronic inflammatory skin diseases. ... Dupixent is a jointly
The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme. ... The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme, and were presented by Dr Hilary Jones.
More from news
Approximately 18 fully matching, plus 80 partially matching documents found.
One example is Genzyme (now Sanofi Genzyme), a pioneer in the rare disease space with a focus on R&D efforts targeting enzyme replacement therapies for lysosomal storage disorders and leading ... including Shire/Takeda, Actelion/J&J, Sanofi Genzyme,
Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme
Client:Sanofi Genzyme. Agency:Vivid – A Lucid Group Company. Campaign:OptiMiSe for MS nurses: a tailored, added-value support service for clinical behaviour change towards optimised services. ... It has also resulted in Sanofi Genzyme SOM-led support
Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.
Client:Sanofi Genzyme. Agency:H4B Manchester. Campaign:The World vs MS. Timescale:Ongoing. The World vs MS is an ongoing, ambitious social movement that has united the world in the fight ... As the world’s first pharma-sponsored emoji, it reinforces
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Rounding out the new hires is Louise Kooij, who joins as head of finance and operations from Sanofi-Genzyme. ... Before this, she held the position of head of business operations Europe at Sanofi-Genzyme Europe, after working as vice president, business
She has worked with global brands including Sanofi Genzyme and Novartis.
Lucid Group had a successful run at the Comm uniqué awards this year, bringing home the Excellence in Professional Education Programmes award for its company Vivid’s work for Sanofi
at Sanofi Genzyme. ... Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.
Sanofi has appointed Bill Sibold as executive vice president for Sanofi Genzyme in a move that will also see he join the company's executive committee. ... Previously head of Sanofi Genzyme’s multiple sclerosis, oncology and immunology organisation,
More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.
AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme. ... Sanofi. Siemens. Teva. UCB. ViiV.
for Sanofi Genzyme. Category: The Real Science Award for Medical Affairs Agency of the Year.
OptiMiSe: a Multichannel Learning Platform for Clinical Behaviour Change Among Multiple Sclerosis Specialist Nurses, by Sanofi Genzyme, with support from Lucid Group.
Could mHealth save healthcare? The rare disease project has really transformed the Sanofi Genzyme rare disease franchise. ... Tom Rigden, Marketing Manager, Rare Disease Portfolio - Sanofi. "I had the pleasure of working with Frontera across a number of
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...